Anti-tuberculosis drug resistance distinctive features -The Republic of Azerbaijan 2012-2013

Irada Akhundova (Baku, Azerbaijan), Irada Akhundova, Elcan Mammedbekov

Source: International Congress 2015 – Management of TB: a patient focus
Session: Management of TB: a patient focus
Session type: Thematic Poster Session
Number: 2745
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Irada Akhundova (Baku, Azerbaijan), Irada Akhundova, Elcan Mammedbekov. Anti-tuberculosis drug resistance distinctive features -The Republic of Azerbaijan 2012-2013. Eur Respir J 2015; 46: Suppl. 59, 2745

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Trend and risk factors of drug resistance tuberculosis between 2005-2012 in Istanbul, Turkey
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015

Dynamics of MBT drug resistance in Saratov Region Hospital, Russia
Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis
Year: 2016

Multidrug–resistant tuberculosis in Czech Republic during the period of recent 5 years (2007-2012)
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II
Year: 2013


Nationwide anti-tuberculosis drug resistance survey in the Republic of Azerbaijan
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014


Indicators of rifampicin-resistant TB response in Belarus, 2009-2014
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016

Factors associated with tuberculosis among prisoners in Bulgaria for the period 2004-2013
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014


Dynamics analysis of MBT drug resistance to antitubercolosis second-line drugs (Saratov region hospital, Russia)
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016

Predisposing factors of multi drug resistant tuberculosis (MDR-TB) in Sardjito Hospital, Yogyakarta, Indonesia in 2009-2012
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Year: 2014

Tuberculosis endemia evolution in Romania’s regions 2008-2011
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I
Year: 2013


Prevalence of drug resistance tuberculosis in the Republic of Moldova during the 1995-2005
Source: Eur Respir J 2007; 30: Suppl. 51, 700s
Year: 2007

Analysis of TB denotifications in North London (2003 – 2012)
Source: Annual Congress 2013 –Epidemiological and public health features of tuberculosis
Year: 2013


Drug resistance among new TB cases in some Russian regions
Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children
Year: 2015


Drug resistance among tuberculosis cases in the European Union and European Economic Area, 2007 to 2012
Source: International Congress 2014 – Tuberculosis: public health and primary prevention
Year: 2014


Treatment outcomes and deaths among multidrug-resistant tuberculosis (MDR-TB) patients in Gomel region, Belarus – 2009-2010
Source: Annual Congress 2013 –Drug-resistant tuberculosis: new clinical and public health insights
Year: 2013


Tuberculosis and HIV infection in combination with multidrug resistant MBT on Northwest of Russia
Source: International Congress 2016 – Epidemiological aspects of tuberculosis and other respiratory conditions: from lung cancer to late-onset Pompe's disease
Year: 2016

Trend in TB control in Republic of Moldova: High MDRTB burden country
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014

Characteristics of patients under treatment for NTM disease during the period 2004-2013 in Greece
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Year: 2014

Risk factors for anti-TB drug resistance in Poland
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management III
Year: 2013

The top of the iceberg - Extensively drug resistant tuberculosis (XDR-TB) in 2010
Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children
Year: 2015


Transmission pattern of MDR-TB in Singapore 2005-2015
Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments
Year: 2016